RadNet, Inc. (RDNT)

Market Cap	4.24B
Revenue (ttm)	1.66B
Net Income (ttm)	21.27M
Shares Out	73.88M
EPS (ttm)	0.30
PE Ratio	191.50
Forward PE	81.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	231,400
Open	58.05
Previous Close	57.58
Day's Range	57.11 - 58.59
52-Week Range	25.11 - 58.59
Beta	1.69
Analysts	Strong Buy
Price Target	57.25 (-0.35%)
Earnings Date	May 8, 2024

About RDNT

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retri...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jul 1, 1986
• Employees: 7,872
• Stock Exchange: NASDAQ
• Ticker Symbol: RDNT

Financial Performance

In 2023, RadNet's revenue was $1.62 billion, an increase of 13.05% compared to the previous year's $1.43 billion. Earnings were $3.04 million, a decrease of -71.42%.

Analyst Forecast

According to 4 analysts, the average rating for RDNT stock is "Strong Buy." The 12-month stock price forecast is $57.25, which is a decrease of -0.35% from the latest price.

Price Target

$57.25

(-0.35% downside)

Analyst Consensus: Strong Buy